| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D C Goff, D C Henderson, A E Evins, E Amic. A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia. Biological psychiatry. vol 45. issue 4. 1999-05-13. PMID:10071726. |
a placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia. |
1999-05-13 |
2023-08-12 |
Not clear |
| S Sous. Refractory schizophrenia: what works pharmacologically? Journal of psychosocial nursing and mental health services. vol 37. issue 2. 1999-05-12. PMID:10023603. |
clozaril is the only antipsychotic medication proven to be effective in treating refractory schizophrenia. |
1999-05-12 |
2023-08-12 |
Not clear |
| S Sous. Refractory schizophrenia: what works pharmacologically? Journal of psychosocial nursing and mental health services. vol 37. issue 2. 1999-05-12. PMID:10023603. |
nurses can be very instrumental in working with resistant systems, treating clinicians, and patients by recommending clozaril therapy for refractory schizophrenia. |
1999-05-12 |
2023-08-12 |
Not clear |
| M Bürg. [Clozapine and obsessive-compulsive symptoms in schizophrenia. A case history of one patient]. Der Nervenarzt. vol 70. issue 1. 1999-04-29. PMID:10087519. |
[clozapine and obsessive-compulsive symptoms in schizophrenia. |
1999-04-29 |
2023-08-12 |
Not clear |
| G Facciolà, A Avenoso, E Spina, E Perucc. Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia. Therapeutic drug monitoring. vol 20. issue 6. 1999-04-27. PMID:9853978. |
inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia. |
1999-04-27 |
2023-08-12 |
Not clear |
| G Facciolà, A Avenoso, E Spina, E Perucc. Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia. Therapeutic drug monitoring. vol 20. issue 6. 1999-04-27. PMID:9853978. |
the steady state plasma concentrations of clozapine and its two major metabolites, norclozapine and clozapine n-oxide, were compared in patients with schizophrenia treated with clozapine in combination with phenobarbital (n=7), and in control patients treated with clozapine alone (n=15). |
1999-04-27 |
2023-08-12 |
Not clear |
| M C Mahoney, B F Connolly, C M Smit. A clozapine overdose with markedly elevated serum levels. Journal of clinical pharmacology. vol 39. issue 1. 1999-04-27. PMID:9987706. |
clozapine (clozaril) is an atypical antipsychotic agent used to treat schizophrenia refractory to other pharmacological agents. |
1999-04-27 |
2023-08-12 |
Not clear |
| M Hummer, G Kemmler, M Kurz, I Kurzthaler, H Oberbauer, W W Fleischhacke. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. The American journal of psychiatry. vol 156. issue 4. 1999-04-21. PMID:10200746. |
sexual disturbances during clozapine and haloperidol treatment for schizophrenia. |
1999-04-21 |
2023-08-12 |
Not clear |
| M Hummer, G Kemmler, M Kurz, I Kurzthaler, H Oberbauer, W W Fleischhacke. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. The American journal of psychiatry. vol 156. issue 4. 1999-04-21. PMID:10200746. |
the aim of this study was to evaluate the frequency and course of sexual disturbances associated with clozapine and haloperidol and their potential influence on compliance with medication regimens in patients with schizophrenia. |
1999-04-21 |
2023-08-12 |
Not clear |
| I Anghelescu, A Szegedi, S Schlegel, H Weigmann, C Hiemke, H Wetze. Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 8. issue 4. 1999-04-13. PMID:9928923. |
combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial. |
1999-04-13 |
2023-08-12 |
Not clear |
| C A Galletly, C R Clark, A C McFarlane, D L Webe. Effects of clozapine for non-treatment-resistant patients with schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 1. 1999-04-07. PMID:9890589. |
effects of clozapine for non-treatment-resistant patients with schizophrenia. |
1999-04-07 |
2023-08-12 |
Not clear |
| C A Galletly, C R Clark, A C McFarlane, D L Webe. Effects of clozapine for non-treatment-resistant patients with schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 1. 1999-04-07. PMID:9890589. |
in this study clozapine was given to 19 patients with schizophrenia who did not meet these criteria and whose symptoms were mild to moderate in severity. |
1999-04-07 |
2023-08-12 |
Not clear |
| M Biondi, L Fedele, T Arcangeli, P Pancher. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychotherapy and psychosomatics. vol 68. issue 2. 1999-03-29. PMID:10026463. |
development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. |
1999-03-29 |
2023-08-12 |
Not clear |
| A J Jenkins, K M Sarconi, H N Raa. Determination of olanzapine in a postmortem case. Journal of analytical toxicology. vol 22. issue 7. 1999-03-24. PMID:9847013. |
it is structurally similar to clozapine, has a low incidence of extrapyramidal effects, and is effective in treating both the positive and negative symptoms of schizophrenia. |
1999-03-24 |
2023-08-12 |
Not clear |
| N Blieden, S Flinders, K Hawkins, M Reid, L D Alphs, C L Arfke. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. Psychiatric services (Washington, D.C.). vol 49. issue 12. 1999-03-22. PMID:9856622. |
health status and health care costs for publicly funded patients with schizophrenia started on clozapine. |
1999-03-22 |
2023-08-12 |
Not clear |
| N Blieden, S Flinders, K Hawkins, M Reid, L D Alphs, C L Arfke. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. Psychiatric services (Washington, D.C.). vol 49. issue 12. 1999-03-22. PMID:9856622. |
the study examined the effect of clozapine treatment on the health care costs and health status of people with schizophrenia who are supported by public funds. |
1999-03-22 |
2023-08-12 |
Not clear |
| M Fin. ECT and clozapine in schizophrenia. The journal of ECT. vol 14. issue 4. 1999-03-17. PMID:9871841. |
ect and clozapine in schizophrenia. |
1999-03-17 |
2023-08-12 |
Not clear |
| S C Bhatia, S K Bhatia, S Gupt. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. The journal of ECT. vol 14. issue 4. 1999-03-17. PMID:9871852. |
concurrent administration of clozapine and ect: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. |
1999-03-17 |
2023-08-12 |
Not clear |
| A Vysokanov, J Flores-Hernandez, D J Surmeie. mRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons. Neuroscience letters. vol 258. issue 3. 1999-03-15. PMID:9885960. |
the clinical efficacy of clozapine in treating schizophrenia may stem from its lack of receptor selectivity. |
1999-03-15 |
2023-08-12 |
rat |
| E Howanitz, M Pardo, D A Smelson, C Engelhart, N Eisenstein, R G Stern, M F Losoncz. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. The Journal of clinical psychiatry. vol 60. issue 1. 1999-03-15. PMID:10074877. |
the efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. |
1999-03-15 |
2023-08-12 |
Not clear |